MeSH D004697 - bacterial endocarditis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Alkem Laboratories | Vancomycin | Vancomycin |  | 2022-11-14 |  |  |
| Allergan | Vancomycin | Vancomycin |  | 2012-04-09 |  |  |
| Amneal Pharmaceuticals | Vancomycin | Vancomycin |  | 2023-06-23 |  |  |
| ANI Pharmaceuticals | Vancomycin | Vancocin |  | 1982-01-01 |  |  |
| Aspiro Pharma | Vancomycin | Vancomycin |  | 2022-07-06 |  |  |
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
50%1/2
Phase 3
100%11/11
Approved: 10Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use